Medications for Transient Ischemic Attack

5 results

  • Brilinta

    (Ticagrelor)
    AstraZeneca Pharmaceuticals LP
    Usage: BRILINTA is indicated for reducing the risk of cardiovascular death, myocardial infarction, and stroke in patients with acute coronary syndrome or a history of myocardial infarction. It also reduces the risk of first myocardial infarction or stroke in high-risk coronary artery disease patients and ischemic stroke/TIA patients.

  • Ticagrelor (ticagrelor)

    (TICAGRELOR)
    Novadoz Pharmaceuticals LLC
    Usage: Ticagrelor is indicated for reducing the risk of cardiovascular death, myocardial infarction, and stroke in patients with acute coronary syndrome or a history of myocardial infarction. It's also used in patients with coronary artery disease at high risk for first MI or stroke, and those with acute ischemic stroke or high-risk TIA.

  • Ticagrelor (ticagrelor)

    (ticagrelor)
    Amneal Pharmaceuticals NY LLC
    Usage: Ticagrelor tablets are indicated for reducing the risk of cardiovascular death, myocardial infarction, and stroke in patients with acute coronary syndrome (ACS) or a history of myocardial infarction. They also prevent stent thrombosis and reduce the risk of first myocardial infarction or stroke in high-risk coronary artery disease patients.

  • Ticagrelor (ticagrelor)

    (TICAGRELOR)
    AvKARE
    Usage: Ticagrelor tablets are indicated for reducing the risk of cardiovascular death, myocardial infarction, and stroke in patients with acute coronary syndrome or a history of myocardial infarction. It also helps prevent first myocardial infarctions or strokes in high-risk patients with coronary artery disease and reduces stroke risk in acute ischemic stroke or high-risk TIA patients.